Index of reports
> Cases with Dyspnoea (99)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 99 Next >>
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-25
Patient:
Reactions: Fatigue, Dyspnoea, Pain
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-03
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-03
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient:
Reactions: Dyspnoea, Fatigue, Dizziness, DRY Skin
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 microgram, qw
Start date: 2012-03-30
Ribasphere
Victrelis
Dosage: 4 df, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-30
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: Injection Site Erythema, Dyspnoea, Fatigue, Pruritus, Rash Erythematous, Rash, Thyroid Function Test Abnormal
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-23
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-23
Possible PEG-Intron side effects in
Reported by a pharmacist from United States on 2012-08-23
Patient:
Reactions: Glaucoma, Dyspnoea
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 microgram, unknown
End date: 2012-07-13
Procrit
Dosage: 1 ml, qw
End date: 2012-07-13
Rebetol
Dosage: 200 mg, unknown
Administration route: Oral
End date: 2012-07-13
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient:
Reactions: Dyspnoea, Hypotension, Anaemia
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Ribasphere
Indication: Hepatitis C
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-23
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: Weight Decreased, Fatigue, Rash Generalised, Dyspnoea, Dizziness, Abdominal Pain Upper
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-10
Ribasphere
Indication: Hepatitis C
Other drugs received by patient: Omeprazole; Losartan Potassium; Ascorbic Acid
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: Pulmonary Hypertension, Dyspnoea, Chest Pain
Drug(s) suspected as cause:
PEG-Intron
Other drugs received by patient: Ribavirin; Vertex Asepta Balm
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient:
Reactions: Gallbladder Pain, Glossodynia, Dyspnoea, Rash, Eructation, Dysgeusia, Irritability, Fatigue, Vision Blurred, Parosmia, Cholecystitis, Gastrooesophageal Reflux Disease
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 micrograms/0.5 milliliters
Rebetol
Dosage: unk mg, unk
Victrelis
Dosage: unk mg, unk
Other drugs received by patient: Doxycycline HCL; Lisinopril; Neurontin; Oxycodone HCL; Omeprazole; Viibryd
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient:
Reactions: Weight Decreased, Pneumonia, Pruritus, Dyspnoea, Nausea, Pain, Haemoglobin Abnormal, Irritability, Diplopia, Fatigue, Lung Disorder, Dizziness, Asthenia, Decreased Appetite, Influenza
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-02-07
Rebetol
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-02-07
Telaprevir
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-02-07
Other drugs received by patient: Morphine; Synthroid; Oxycodone HCL; Nexium
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient:
Reactions: Ischaemia, Dyspnoea, Pain, Pancytopenia, Headache, Optic Neuropathy, Fatigue, Ocular Hyperaemia, Dizziness, Influenza Like Illness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.5 ml, unk
Indication: Hepatitis C
Start date: 2012-03-01
End date: 2012-04-01
PEG-Intron
Dosage: 0.4 ml, unk
Start date: 2012-04-01
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-01
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-22
Patient:
Reactions: Fatigue, Dyspnoea, Pruritus, Injection Site Erythema, Rash Erythematous, Rash, Thyroid Function Test Abnormal
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-23
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-23
Possible PEG-Intron side effects in
Reported by a pharmacist from United States on 2012-08-22
Patient:
Reactions: Confusional State, Dyspnoea, Nausea, Anaemia, Rectal Haemorrhage, DRY Skin, Amnesia, Fatigue, Diarrhoea, DRY Mouth, Alopecia, Anorectal Discomfort, Depressed Mood, Injection Site Exfoliation, Aphonia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 180 microgram, qw, per injection
Rebetol
Dosage: unk
Other drugs received by patient: Tricor; Micardis; Omega-3-Acid Ethyl Esters; Wellbutrin; Cardura; Vitamin E; Glucosamine
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-22
Patient:
Reactions: Metabolic Acidosis, Dyspnoea, Diarrhoea, Hypophagia, Bronchitis, Pyrexia, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Boceprevir
Dosage: a
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-04
Blinded MK-5172
Dosage: a
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-04
Blinded Post Trial Therapy
Dosage: a
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-04
Blinded PRE Trial Therapy
Dosage: a
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Blinded Therapy
Dosage: f
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Blinded Therapy
Dosage: h
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Dosage: c
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Dosage: g
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Blinded Therapy
Dosage: e
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Dosage: d
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Dosage: b
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-04
Blinded Therapy
Dosage: 4 df, tid
Administration route: Oral
Start date: 2012-02-08
End date: 2012-06-24
Blinded Therapy
Blinded Therapy
Blinded Therapy
Blinded Therapy
Indication: Hepatitis C
Blinded Therapy
PEG-Intron
Indication: Hepatitis C
PEG-Intron
Dosage: 0.5 ml, qw
Administration route: Oral
Start date: 2012-01-10
End date: 2012-06-19
Peginterferon Alfa-2B
Dosage: a
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-04
Placebo
Dosage: a
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-04
Rebetol
Dosage: 3 df, qam
Administration route: Oral
Start date: 2012-01-11
End date: 2012-04-10
Rebetol
Dosage: 3 df, qpm
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-06
Rebetol
Dosage: 2 df, qpm
Administration route: Oral
Start date: 2012-04-07
End date: 2012-06-24
Rebetol
Dosage: 2 df, qam
Administration route: Oral
Start date: 2012-05-01
End date: 2012-06-24
Rebetol
Dosage: 3 df, qam
Administration route: Oral
Start date: 2012-04-17
End date: 2012-04-30
Rebetol
Dosage: 2 df, qam
Administration route: Oral
Start date: 2012-04-11
End date: 2012-04-16
Ribavirin
Dosage: a
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-11
End date: 2012-04-04
Other drugs received by patient: Protonix; Paxil; Protonix; Lisinopril; Paxil; Lisinopril
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-17
Patient:
Reactions: White Blood Cell Count Decreased, Weight Decreased, Dyspnoea, Nausea, Diabetes Mellitus, Hypotension, Anaemia, Rash, Headache, Therapeutic Product Ineffective, Dysgeusia, Fatigue, RED Blood Cell Count Decreased, Asthenia, Lethargy, Epistaxis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2008-01-04
End date: 2008-10-03
PEG-Intron
Dosage: unk unk, unknown
Start date: 2011-08-17
End date: 2012-04-03
PEG-Intron
Dosage: unk unk, unknown
End date: 2009-10-07
PEG-Intron
Dosage: 0.4 ?g, unknown
PEG-Intron
Dosage: 0.3 ?g, unknown
Ribavirin
Dosage: unk unk, unknown
End date: 2009-10-07
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2008-01-04
End date: 2008-10-03
Ribavirin
Dosage: 200 mg, qd
Ribavirin
Dosage: unk unk, qd
Ribavirin
Dosage: unk unk, qd
Start date: 2011-08-17
End date: 2012-04-03
Ribavirin
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-14
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2011-09-14
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2011-09-14
Other drugs received by patient: Epoetin Alfa
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-10
Patient:
Reactions: Weight Decreased, Haemoglobin Decreased, Dyspnoea, Transfusion, Decreased Appetite, Hypersomnia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-22
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-22
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-20
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-09
Patient:
Reactions: Wrong Technique in Drug Usage Process, Syncope, Dyspnoea, Asthenia, Blood Pressure Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 micrograms, qw
Indication: Hepatitis C
Start date: 2012-05-01
Rebetol
Indication: Hepatitis C
Other drugs received by patient: Tranxene; Effexor; Lisinopril; Synthroid; Paxil; Ondansetron
Possible PEG-Intron side effects in
Reported by a individual with unspecified qualification from United States on 2012-08-06
Patient:
Reactions: Dyspnoea, Retching, Nausea, Pyrexia, Constipation, Fatigue, Palpitations, Dizziness, Asthenia, Influenza Like Illness
Drug(s) suspected as cause:
Boceprevir
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
PEG-Intron
Dosage: 150 ?g, unknown
Indication: Hepatitis C
Rebetol
Dosage: 200 mg, unknown
Indication: Hepatitis C
Other drugs received by patient: Estradiol (+) Norethindrone; Tylenol (Caplet); Neupogen; Prochlorperazine; Procrit; Prozac
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03
Patient:
Reactions: Weight Decreased, Head Injury, Teeth Brittle, Loss of Consciousness, Malaise, Fatigue, Oral Candidiasis, Hyperchlorhydria, Depression, Decreased Appetite, Hypersomnia, Tooth Fracture, Dyspnoea, Vomiting, Anaemia, Rash, Dysgeusia, Anxiety, Alopecia, Insomnia, Hypophagia, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-10-25
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-10-25
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-11-23
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03
Patient:
Reactions: Dyspnoea, Musculoskeletal Stiffness, Rash
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 microgram, qw
Indication: Hepatitis C
Start date: 2012-02-28
Ribasphere
Indication: Hepatitis C
Telaprevir
Indication: Hepatitis C
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-01
Patient:
Reactions: Night Sweats, Abdominal Pain, Contusion, Chills, Wheezing, Pyrexia, Change of Bowel Habit, Constipation, Hyperhidrosis, Joint Stiffness, Hepatomegaly, Laboratory Test Abnormal, Fatigue, Haematocrit Decreased, RED Blood Cell Count Decreased, Dizziness, Melaena, White Blood Cell Count Decreased, Dyspnoea, Hepatic Fibrosis, Haemorrhoids, Incorrect Dose Administered, Laceration, Hepatic Steatosis, Haemoglobin Decreased, Impaired Healing, Diarrhoea, Arthralgia, Insomnia, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 180 microgram, qd
Pegasys
Dosage: 180mcg,once a week
Rebetol
Dosage: 1200 mg, qd
Victrelis
Dosage: 200mg,4tablets,three times a day
Other drugs received by patient: Allegra-D 12 Hour; Omeprazole; Milk Thistle; Zolpidem Tartrate; Citalopram Hydrobromide; Echinacea (Unspecified)
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Greece on 2012-08-01
Patient:
Reactions: Dyspnoea, Fatigue, Pulmonary Embolism, Pleural Effusion, Pyrexia, Cardiac Disorder
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 unk, unk
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2012-07-03
Rebetol
Dosage: 1200 mg, unk
Indication: Hepatitis C
Start date: 2011-09-20
End date: 2012-07-03
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01
Patient:
Reactions: Dyspnoea, Anaemia, Rash, Headache, Generalised Oedema, Anxiety, Gastrointestinal Pain, Fatigue, Diarrhoea, Visual Impairment, Depression, Mood Swings, Cough, Decreased Appetite
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-07-16
Ribasphere
Dosage: unk
Start date: 2012-04-27
End date: 2012-07-16
Telaprevir
Dosage: unk
Possible PEG-Intron side effects in
Reported by a pharmacist from United States on 2012-08-01
Patient:
Reactions: Dyspnoea, Fatigue, Injection Site Reaction, Insomnia, Gastric Disorder
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Indication: Hepatitis C
Start date: 2012-06-21
Ribasphere
Dosage: 600 mg, bid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Telaprevir
Dosage: 750 mg, tid
Indication: Product Used FOR Unknown Indication
Possible PEG-Intron side effects in
Reported by a physician from Hungary on 2012-08-01
Patient:
Reactions: Dyspnoea, Febrile Neutropenia, Bacterial Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 ?g, qw
Indication: Hepatitis C
Start date: 2011-10-02
Rebetol
Dosage: unk
Victrelis
Other drugs received by patient: Bebetina; Famotidine; Allopurinol
Possible PEG-Intron side effects in
Reported by a individual with unspecified qualification from United States on 2012-07-31
Patient:
Reactions: Dyspnoea, Drug Ineffective, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-01-01
End date: 2012-06-01
PEG-Intron
Dosage: unk
Start date: 2012-06-30
End date: 2012-07-17
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-01-01
End date: 2012-06-01
Rebetol
Dosage: unk
Start date: 2012-06-30
End date: 2012-07-17
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30
Patient:
Reactions: Dyspnoea, Fatigue, Ocular Hyperaemia, Pain, Dizziness, Headache, Influenza Like Illness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.5 ml, unk
Indication: Hepatitis C
Start date: 2012-03-01
End date: 2012-04-01
PEG-Intron
Dosage: 0.4 ml, unk
Start date: 2012-04-01
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-01
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-07-25
Patient:
Reactions: Dyspnoea, Syncope, Wrong Technique in Drug Usage Process, Blood Pressure Decreased, Asthenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 micrograms, qw
Indication: Hepatitis C
Start date: 2012-05-01
Rebetol
Indication: Hepatitis C
Other drugs received by patient: Lisinopril; Ondansetron; Effexor; Synthroid; Paxil; Tranxene
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-25
Patient:
Reactions: Vomiting, Rash Generalised, Dyspnoea, Nausea, Anaemia, Headache, Generalised Oedema, Anxiety, Fatigue, Diarrhoea, Mood Swings, Depression, Blindness, Muscle Spasms, Decreased Appetite, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Indication: Hepatitis C
Start date: 2012-04-27
Ribasphere
Dosage: unk
Start date: 2012-04-27
Telaprevir
Possible PEG-Intron side effects in
Reported by a physician from Greece on 2012-07-24
Patient:
Reactions: Dyspnoea, Fatigue, Pleural Effusion, Pulmonary Embolism, Pyrexia, Cardiac Disorder
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 unk, unk
Indication: Hepatitis C
End date: 2012-07-03
Rebetol
Dosage: 1200 microgram, unk
Indication: Hepatitis C
End date: 2012-07-03
Possible PEG-Intron side effects in male
Reported by a individual with unspecified qualification from United States on 2012-07-17
Patient: male
Reactions: Fatigue, Dyspnoea, Pruritus, Injection Site Erythema, Rash, Thyroid Function Test Abnormal
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-23
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-23
Page 1 Next >>
|